Karine Celli‐Lebras

Centre Hospitalier Universitaire de Bordeaux — France

Medicine · Health Sciences

18h-index1.8kcitations69works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(53), Acute Lymphoblastic Leukemia research(16), Cancer Genomics and Diagnostics(15), Myeloproliferative Neoplasms: Diagnosis and Treatment(13), Histone Deacetylase Inhibitors Research(9)

Publications68 total

Real-world patterns of treatment intensity and prognostic model performance in older AML: Insights from the french ALFA-PPP cohort
Blood·2025Open Access
Randomized study of high-dose cytarabine with or without dexamethasone as post-remission therapy in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups
Blood·2025
Therapy-related core binding factor Acute Myeloid Leukemia – a Study of the french acute leukemia intergroup
Blood·2025Open Access
Impact of midostaurin in younger AML patients intensively treated with high-dose anthracycline
Blood·2025Open Access
Secondary-type acute myeloid leukemia is associated with a higher risk of invasive fungal infection during intensive induction therapy. a correlative study on the ALFA 0702 trial.
Blood·2025Open Access
Frequency and impact of FLT3-ITD microclones in younger AML patients
Blood·2025
Real-life CD34+CD38- leukemic stem cell (LSC) flow quantification in adult AML at diagnosis independently predicts survival of intensively but not AZA-VEN treated patients: A study of prospective observational ALFA-PPP acute leukemia french association
Blood·2025
Induction chemotherapy with a single anthracycline-containing cycle in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups
Blood·2025
Real life treatments and outcomes of older patients aged more than 60 years with FLT3-mutated acute myeloid leukemia: Report from the multicentric french observational ALFA-PPP study
Blood·2025Open Access
Intermediate-Dose Cytarabine as Postinduction AML Therapy
NEJM Evidence·2025· 5 cited
Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles
European Journal Of Haematology·2025Open Access
Secondary Genetic Alterations and Measurable Residual Disease in Core Binding Factor Acute Myeloid Leukemia - a Study from the Acute Leukemia French Intergroup
Blood·2024Open Access
Treatments and Outcomes of Adult Patients with AML in the Real-Life - First Report of the French Observational ALFA-PPP Study
Blood·2024Open Access
Flow MRD Monitoring Combining Laip/Dfn and CD34+CD38- LSCs Is a Strong Predictor of Outcome in Adult AML Independently of the ELN-2022 Risk: First Results from the Multicentric Acute Leukemia French Intergroup MRD Flow Network
Blood·2024· 4 citedOpen Access
IL-1RAP Is a Targetable Surface Antigen in Relapsed/Refractoy AML
Blood·2024Open Access
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study
Blood Cancer Journal·2024· 8 citedOpen Access
Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups
Blood·2023· 5 cited
Venetoclax in Combination with Intermediate Doses of Cytarabine in Consolidation Phase for Acute Myeloid Leukemia Patients in First Complete Remission; Results of the Part 1 of the Phase 1/2 Multicentric Covenidac Study
Blood·2023· 2 cited
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
Blood Advances·2023· 8 citedOpen Access
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia
Leukemia·2023· 28 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Hervé Dombret(44), Claude Preudhomme(42), Xavier Thomas(29), Emmanuel Raffoux(29), Nicolas Duployez(29), Nicolas Boissel(27), Christine Terré(26), Céline Berthon(24), Raphaël Itzykson(24), Cécile Pautas(21), Stéphane de Botton(17), Émilie Lemasle(17), Sylvain Chantepie(17), Juliette Lambert(16), Sylvie Castaigné(16), Christian Récher(16), Claude Gardin(15), Alice Marceau‐Renaut(13), Olivier Nibourel(13), Arnaud Pigneux(13)